Menu Back to 7th-Annual-Conference-in-Japan-for-Asian-New-Drug-Development

Program Committee

  • Kihito  Takahashi, MD, PhD
    Kihito Takahashi, MD, PhD VP and Senior Managing Director, Development & Medical Affairs Division
    GlaxoSmithKline K.K., Japan
  • Tetsuomi  Takano, RPh
    Tetsuomi Takano, RPh Senior Director, Head of Asian Development Strategy
    Astellas Pharma Inc., Japan
  • Yuko  Kikuchi
    Yuko Kikuchi Senior Director, Asia Regulatory Affairs
    Eisai Co., Ltd., Japan
  • Koichi  Miyazaki, MSc, RPh
    Koichi Miyazaki, MSc, RPh Senior Director, Regulatory Affairs Group, Asia Development Dept., R&D Div.
    Daiichi Sankyo Co., Ltd., Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Head, Regulatory Operation & Prescribing Information Group, Drug RA Dept.
    Novartis Pharma K.K., Japan
  • Yoshihiko  Ono, RPh
    Yoshihiko Ono, RPh Executive Director, Head of Regulatory Affairs, Japan Development
    MSD K.K., Japan
  • Yasuto  Otsubo
    Yasuto Otsubo
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Akio  Uemura, PhD
    Akio Uemura, PhD Corporate Officer, Senior Director and Head, Drug Development Operations Japan
    Allergan Japan K.K., Japan
  • Yoshiaki  Uyama, PhD
    Yoshiaki Uyama, PhD Director, Office of Medical Informatics and Epidemiology
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Load More